NRx Pharmaceuticals, Inc. (NRXPW) NASDAQ

0.08

+0.0001(+0.12%)

Updated at September 08 04:00PM

Currency In USD

NRx Pharmaceuticals, Inc.

Address

1201 Orange Street

Wilmington, DE 19801

United States of America

Phone

484 254 6134

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

First IPO Date

December 01, 2017

Key Executives

NameTitlePayYear Born
Mr. Matthew Patrick DuffyChief Business Officer & Co-Chief Executive Officer of Hope Therapeutics338,0001963
Dr. Jonathan C. Javitt M.D., M.P.H.Co-Founder, Chief Scientist Officer, Chairman & Interim Chief Executive Officer825,0001957
Dr. Riccardo Panicucci Ph.D.Chief Manufacturing & Technology Officer240,0001961
Mr. Michael S. AbramsChief Financial Officer01970
Suzanne MessereInvestor Relations0N/A
Dr. Philip T. Lavin Ph.D.Chief Methodologist01947

Description

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.